Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-22

FDA Approved: OXCARBAZEPINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

The FDA approved Ajanta Pharma USA Inc.'s generic oxcarbazepine through an original application. It is indicated for the treatment of partial seizures in adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)